Earnings Preview: IRadimed to Report Financial Results Pre-market on May 05
IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
IRADIMED (NASDAQ:IRMD) Is Achieving High Returns On Its Capital
Here's Why We Think IRADIMED (NASDAQ:IRMD) Is Well Worth Watching
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
IRadimed | 10-K: FY2024 Annual Report
Earnings Update: Here's Why Analysts Just Lifted Their IRADIMED CORPORATION (NASDAQ:IRMD) Price Target To US$71.00
IRadimed Analyst Ratings
Lake Street Maintains IRadimed(IRMD.US) With Buy Rating, Raises Target Price to $70
Is Weakness In IRADIMED CORPORATION (NASDAQ:IRMD) Stock A Sign That The Market Could Be Wrong Given Its Strong Financial Prospects?
Roth MKM Maintains IRadimed(IRMD.US) With Buy Rating, Raises Target Price to $72
Wall Street Analysts Are Bullish on Top Healthcare Picks
IRADIMED CORPORATION Reports Record Revenue Growth
IRadimed To Go Ex-Dividend On February 24th, 2025 With 0.17 USD Dividend Per Share
Earnings Call Summary | IRadimed(IRMD.US) Q4 2024 Earnings Conference
IRadimed Raises Quarterly Dividend to $0.17 a Share From $0.15, Payable March 5 to Shareholders as of Feb. 24
Express News | Iradimed Shares Are Trading Lower. The Company Reported Q4 Financial Results